Our study found that UGTA1A, NQO1 and GSTA gene expression levels in lung cancer tissues carrying KEAP1/NRF2 gene mutations significantly increased in comparison with those in lung cancer tissues without KEAP1/NRF2 gene mutations. This evidence concerns the gene NQO1 and lung carcinoma.